COVID-19 Convalescent Plasma: from donation to treatment - A Systematic Review & Single Center Experience

Mo Med. Jan-Feb 2021;118(1):74-80.

Abstract

Convalescent plasma is an old treatment for a new disease. The coronavirus disease 2019 (COVID-19) pandemic caused the analysis of convalescent plasma to reemerge as a possible treatment. First, a systematic review summarizes the available research examining the use of convalescent plasma for the treatment of patients with COVID-19. Second, we describe our experience in establishing a single-center convalescent plasma donation program.

Publication types

  • Systematic Review

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Blood Donors / statistics & numerical data
  • Blood Donors / supply & distribution*
  • COVID-19 / diagnosis
  • COVID-19 / epidemiology
  • COVID-19 / therapy*
  • COVID-19 / virology
  • Donor Selection / methods
  • Female
  • Humans
  • Immunization, Passive / methods*
  • Male
  • Middle Aged
  • SARS-CoV-2 / genetics
  • SARS-CoV-2 / isolation & purification
  • Treatment Outcome

Supplementary concepts

  • COVID-19 serotherapy